Evidence map›Paper›PMID 28383684›Full record

SynthesisCarcinogenesis2017

Functional variants in DCAF4 associated with lung cancer risk in European populations.

Hongliang Liu, Zhensheng Liu, Yanru Wang, Thomas E Stinchcombe, Kouros Owzar, Younghun Han, Rayjean J Hung, Yonathan Brhane, John McLaughlin, Paul Brennan and 13 more

Open access · bronzeAbstract readMeta-Analysis
In one paragraph

Synthesis in Carcinogenesis, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Potentially Functional Variants of ATG16L2 Predict Radiation Pneumonitis and Outcomes in Patients with Non-Small Cell Lung Cancer after Definitive Radiotherapy.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 14 institutions in 6 countries.

Hongliang LiuDuke Cancer Institute, Duke University Medical Center, Durham, NC 27710, USA.
Zhensheng LiuDuke Cancer Institute, Duke University Medical Center, Durham, NC 27710, USA.
Yanru WangDuke Cancer Institute, Duke University Medical Center, Durham, NC 27710, USA.
Thomas E StinchcombeDuke Cancer Institute, Duke University Medical Center, Durham, NC 27710, USA.
Kouros OwzarDuke Cancer Institute, Duke University Medical Center, Durham, NC 27710, USA.
Younghun HanCommunity and Family Medicine, Geisel School of Medicine, Dartmouth College, Hanover, NH 03755, USA.
Rayjean J HungLunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario M5G 1X5,Canada.
Yonathan BrhaneLunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario M5G 1X5,Canada.
John McLaughlinPublic Health Ontario, Toronto, Ontario M5T 3L9, Canada.
Paul BrennanGenetic Epidemiology Group, International Agency for Research on Cancer, 69372 Lyon, France.
Heike BickeböllerDepartment of Genetic Epidemiology, University Medical Center, Georg-August-University Göttingen, 37073 Göttingen, Germany.
Albert RosenbergerDepartment of Genetic Epidemiology, University Medical Center, Georg-August-University Göttingen, 37073 Göttingen, Germany.
Richard S HoulstonDivision of Genetics and Epidemiology, the Institute of Cancer Research, London SW7 3RP, UK.
Neil CaporasoDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Maria T LandiDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Irene BrüskeHelmholtz Centre Munich, German Research Centre for Environmental Health, Institute of Epidemiology I, 85764 Neuherberg, Germany.
Angela RischDepartment of Molecular Biology, University of Salzburg, 5020 Salzburg, Austria.
Xifeng WuDepartment of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Yuanqing YeDepartment of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
David C ChristianiMassachusetts General Hospital, Boston, MA 02114, USA and.
Christopher I AmosCommunity and Family Medicine, Geisel School of Medicine, Dartmouth College, Hanover, NH 03755, USA.
Qingyi WeiDuke Cancer Institute, Duke University Medical Center, Durham, NC 27710, USA.
Transdisciplinary Research in Cancer of the Lung (TRICL) Research Team
Duke Medical Center · USDartmouth College · USNational Cancer Institute · USThe University of Texas MD Anderson Cancer Center · USUniversity of Göttingen · DECentre International de Recherche sur le Cancer · FRDuke University · USHelmholtz Zentrum München · DEInstitute of Cancer Research · GBLunenfeld-Tanenbaum Research Institute · CAMassachusetts General Hospital · USMount Sinai Hospital · CAPublic Health Ontario · CAUniversity of Salzburg · AT

Funding

Women's Cancer Research ProgramP30CA014236 · NCI · DUKE UNIVERSITY · PI JOHN N. NORTON · 1985 to 2026
$174.8M
Translational Engineering in Cancer (TEC)P30CA023108 · NCI · DARTMOUTH COLLEGE · PI Fred W Kolling IV · 1985 to 2026
$91.3M
JH/CIDR Genotyping for Genome-Wide Association StudiesU01HG004438 · NHGRI · JOHNS HOPKINS UNIVERSITY · PI VALLE, DAVID · 2007 to 2011
$24.2M
Translational studies of Hsp90 inhibitors in NSCLCP50CA090578 · NCI · DANA-FARBER CANCER INST · PI YEAP, BEOW Y · 2008 to 2012
$11.4M
Statistical Methods for Analysis of Massive Genetic and Genomic Data in Cancer ResearchR35CA197449 · NCI · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI XIHONG LIN · 2015 to 2026
$10.9M
Transdisciplinary Research in Cancer of the Lung (TRICL)U19CA148127 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI AMOS, CHRISTOPHER I., LE MARCHAND, LOIC · 2010 to 2014
$10.9M
Genes contributing to nicotine dependence in humansR01DA017932 · NIDA · DECODE GENETICS, INC. · PI STEFANSSON, KARI · 2005 to 2015
$9.6M
Genome Wide Association Coordinating CenterU01HG004446 · NHGRI · UNIVERSITY OF WASHINGTON · PI WEIR, BRUCE S. · 2007 to 2011
$6.6M
Molecular and Genetic Analysis of Lung Cancer SurvivalR01CA092824 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI CHRISTIANI, DAVID C · 2002 to 2013
$5.9M
ECOGENETIC STUDY OF LUNG CANCER IN MINORITIESR01CA055769 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI SPITZ, MARGARET R · 1991 to 2008
$5.3M
SPORE in Lung CancerP20CA090578 · NCI · DANA-FARBER CANCER INSTITUTE · PI JOHNSON, BRUCE E. · 2003 to 2007
$5.1M
GENETIC SUSCEPTIBILITY TO LUNG CANCERR01CA074386 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI CHRISTIANI, DAVID C · 1997 to 2008
$4.8M
Cancer Research UK C1298/A8362Cancer Research UK C1298/A8780NCI NIH HHS K07 CA160753NCI NIH HHS N01 CN25404NCI NIH HHS N01 CN25476NCI NIH HHS N01 CN25511NCI NIH HHS N01 CN25512NCI NIH HHS N01 CN25513NCI NIH HHS N01 CN25514NCI NIH HHS N01 CN25515NCI NIH HHS N01 CN25516NCI NIH HHS N01 CN25518NCI NIH HHS N01 CN25522NCI NIH HHS N01 CN25524NCI NIH HHS N01 CN75022NCI NIH HHS P20 CA090578NCI NIH HHS P30 CA014236NCI NIH HHS P30 CA023108NCI NIH HHS P50 CA090578NCI NIH HHS R01 CA055769NCI NIH HHS R01 CA074386NCI NIH HHS R01 CA092039NCI NIH HHS R01 CA092824NCI NIH HHS R01 CA111703NCI NIH HHS R01 CA121197NCI NIH HHS R01 CA127219NCI NIH HHS R01 CA133996NCI NIH HHS R35 CA197449NCI NIH HHS U19 CA148127NHGRI NIH HHS HHSN268200782096CNHGRI NIH HHS U01 HG004438NHGRI NIH HHS U01 HG004446NIDA NIH HHS R01 DA017932Wellcome TrustWorld Health Organization 001
6 · The paper itself

Abstract

Cullin-RING ubiquitin ligases (CRLs) responsible for substrate specificity of ubiquitination play a key role in cell-cycle control and DNA damage response. In this study, we assessed associations between 16 599 SNPs in 115 CRL genes and lung cancer risk by using summary data of six published genome-wide association studies (GWASs) of 12 160 cases and 16 838 cases of European ancestry. As a result, we identified three independent SNPs in DCAF4 (rs117781739, rs12587742 and rs2240980) associated with lung cancer risk (odds ratio = 0.91, 1.09 and 1.09, respectively; 95% confidence interval = 0.88-0.95, 1.05-1.14 and 1.05-1.13, respectively; and P = 3.99 × 10-6, 4.97 × 10-5 and 1.44 × 10-5, respectively) after multiple comparison correction by a false discovery rate <0.05. Since SNP rs12587742 is located within the promoter region and one CpG island of DCAF4, we further performed in silico functional analyses and found that the rs12587742 variant A allele was associated with an increased mRNA expression (P = 2.20 × 10-16, 1.79 × 10-13 and 0.001 in blood cells, normal lung tissues and tumor tissues of lung squamous carcinoma, respectively) and a decreased methylation status (P = 2.48 × 10-9 and 0.032 in adipose and lung tumor tissues, respectively). Moreover, evidence from differential expression analyses further supported an oncogenic effect of DCAF4 on lung cancer, with higher mRNA levels in both lung squamous carcinoma and adenocarcinoma (P = 4.48 × 10-11 and 1.22 × 10-9, respectively) than in adjacent normal tissues. Taken together, our results suggest that rs12587742 is associated with an increased lung cancer risk, possibly by up-regulating mRNA expression and decreasing methylation status of DCAF4.

Indexed as

Genetic Association StudiesGenetic Predisposition to DiseaseGenetic VariationCarrier ProteinsCase-Control StudiesComputational BiologyDNA MethylationGene Expression ProfilingGenome-Wide Association StudyHumansLinkage DisequilibriumLung NeoplasmsOdds RatioPolymorphism, Single NucleotideRiskRisk FactorsCarrier ProteinsDCAF4 protein, human

Identifiers

PMID28383684
PMCPMC6074950
OpenAlexW2604652547

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.